| Application no. and date | 16769872.9 (espacenet) (Federated) (European Patent Register), 20160826 | | Patent/reg. no. and date | DK/EP 3341380, 20191113 | | Publication date | 20180704 | | Priority no. and date | WO PCT/EP2015/069601, 20150827, EP 15188368, 20151005 | | EP pub. no. and date |
EP 3341380 20180704 | | Effective date | | | Applicant/owner | Prexton Therapeutics SA, 14 Chemin des Aulx
1228 Plan les Ouates, Geneva, CH | | Applicant ref. no. | P70476DK01 | | Inventor | CHARVIN, Delphine, 487, rue des vertes campagnes
01170 Gex, FR,
CONQUET, François, 86, route des Pitons
74160 Beaumont, FR | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/407 (2006.01) , A61P 25/16 (2006.01) , C07D 495/04 (2006.01) | | Title | HJERNEGENNEMTRÆNGELIG CHROMONOXIMDERIVAT TIL TERAPIEN AF LEVODOPA-INDUCERET DYSKINESI | | Int. application no. | EP2016070175 | | Int. publication no. | WO2017032874 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
